Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Immunity & Ageing

Fig. 2

From: CD57+ EMRA CD8+ T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapy

Fig. 2

Mean fluorescence intensity of Sestrin-2, granzyme B, and Ki-67 across CD8+ T cells maturation stages. The mean fluorescence intensity (MFI) of Sestrin-2, granzyme B, and Ki-67 was measured across different stages of CD8 + T cell maturation, ranging from the least differentiated (naïve) to the most differentiated (CD57 + DAP12 + EMRA) cells (n = 35). CM: central memory; EM: effector memory. Differences between the two groups were tested using a two-sided unpaired t-test. The p-values are indicated by asterisks as follows: < 0.05*, < 0.01**, < 0.001***, < 0.0001****

Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us